Results 251 to 260 of about 825,921 (342)

Pilot Study on Evaluation of Clinical Pharmacy Practice at National Cardiovascular Center

, 2004
Takeshi Kotake, Yuka Shimeda, Tanaka Kazuhiko, Michitaka Takada, Masahiko Shibakawa   +4 more
openalex   +2 more sources

Clinical Pharmacy: The Terminal Pharmacy Course

American Journal of Pharmaceutical Education, 1968
openaire   +1 more source

PRELIVE: A Framework for Predicting Lipid Nanoparticles In Vivo Efficacy and Reducing Reliance on Animal Testing

Advanced Functional Materials, EarlyView.
PREdicting LNP In Vivo Efficacy (PRELIVE) framework enables the prediction of lipid nanoparticle (LNPs) organ‐specific delivery through dual modeling approaches. Composition‐based models using formulation parameters and protein corona‐based models using biological fingerprints both achieve high predictive accuracy across multiple organs.
Belal I. Hanafy, Chuan‐En Lu, Kai Liu, Audrey Gallud   +3 more
wiley   +1 more source

Improving the provision of clinical pharmacy services in low- and middle-income countries: a qualitative study in tertiary health facilities in Tanzania. [PDF]

BMJ Public Health
Mwakawanga DL, Mutagonda RF, Mlyuka HJ, Mikomangwa WP, Kilonzi M, Kibanga WA, Marealle AI, Mallya B, Katabalo D, Sanga S, Kalokola F, Rwegasha J, Magambo R, Mmassy J, Kabissi S, Balati JA, Maduki P, Minzi OM, Kamuhabwa AAR.   +18 more
europepmc   +1 more source

Implementation of Bedside Training and Advanced Objective Structured Clinical Examination (OSCE) Trial to Learn and Confirm about Pharmacy Clinical Skills

, 2013
Jin Tokunaga, Norito Takamura, Kenji Ogata, Nao Setoguchi, Keizo Sato   +4 more
openalex   +2 more sources

Drug‐Free Thrombolysis Mediated by Physically Activated Micro/Nanoparticles

Advanced Functional Materials, EarlyView.
Overview of particle‐mediated thrombolytic effects (thermal, mechanical, and chemical) and their activating physical stimuli (light, ultrasound, and magnetic field) in drug‐free thrombolysis. ABSTRACT Thrombus‐associated disorders rank among the world's leading causes of death, with ischemic heart disease and stroke as the main contributors.
Pierre Sarfati, Yoann Lalatonne, Cédric Chauvierre   +2 more
wiley   +1 more source

Development of an innovative clinical pharmacy service in a urology surgical unit: a new initiative from Qatar. [PDF]

J Pharm Policy Pract
Naseralallah L, Koraysh S, Isleem N, Ahmed A, Al Hail M.   +4 more
europepmc   +1 more source

Poly(lactic‐co‐glycolic acid) Nanoparticles for IL‐12 Self‐Amplifying RNA Delivery in Glioblastoma Models

Advanced Functional Materials, EarlyView.
xxxx. ABSTRACT Glioblastoma (GBM) remains one of the most lethal brain cancers, with median survival rarely exceeding 15 months after diagnosis. Interleukin‐12 (IL‐12) is a potent immunostimulatory cytokine capable of reshaping the tumor microenvironment (TME), yet its clinical translation is hindered by systemic toxicity and short half‐life. RNA‐based
Fatima Hameedat, Johan Sebastian Lopez‐Parra, Willem M. H. Hoogaars, Emma Dijkstra, Cynthia Huang, Irafasha C. Casmil, Anna K. Blakney, Peter Olinga, Barbara Rothen‐Rutishauser, Hélder A. Santos, Alke Petri‐Fink, Flávia Sousa   +11 more
wiley   +1 more source

Clinical Outcomes Associated with the Implementation of a Dedicated Clinical Pharmacy Service in a Resource-Limited Neurocritical Intensive Care Unit. [PDF]

Hosp Pharm
Sa E, Cho Y, Suh SY, Park TE, Rhie SJ.
europepmc   +1 more source